Interleukin enhancer-binding factor 3 (ILF3) Peptide
ILF3
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all Interleukin enhancer-binding factor 3 (ILF3) products
- Interleukin enhancer-binding factor 3 (ILF3)
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- ALKAVSDWID EQEKGSSEQA ESDNMDVPPE DDSKEGAGEQ KTEHMTRTLR
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ILF3 antibody,
Alternative Names: ILF3 control peptide, ILF3 antibody Blocking Peptide, Anti-ILF3 Blocking Peptide, Interleukin Enhancer Binding Factor 3 90Kda Blocking Peptide, ILF3, ILF-3, ILF 3, ILF-3 Blocking Peptide, ILF 3 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- Interleukin enhancer-binding factor 3 (ILF3)
- Background
- ILF3 may facilitate double-stranded RNA-regulated gene expression at the level of post-transcription. ILF3 can act as a translation inhibitory protein which binds to coding sequences of acid beta-glucosidase (GCase) and other mRNAs and functions at the initiation phase of GCase mRNA translation, probably by inhibiting its binding to polysomes. ILF3 can regulate protein arginine N-methyltransferase 1 activity.
- Molecular Weight
- 76 kDa
-
You are here:
